Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.
第一作者:
Sana M,Al-Khatib
第一单位:
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA. alkha001@mc.duke.edu
作者:
医学主题词
年龄因素(Age Factors);老年人(Aged);死亡原因(Cause of Death);共病现象(Comorbidity);猝死, 心脏(Death, Sudden, Cardiac);除颤器, 植入型(Defibrillators, Implantable);合格鉴定(Eligibility Determination);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);男(雄)性(Male);中年人(Middle Aged);一级预防(Primary Prevention);倾向性评分(Propensity Score);随机对照试验(主题)(Randomized Controlled Trials as Topic);登记(Registries);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis)
DOI
10.1001/jama.2012.157182
PMID
23280225
发布时间
2024-03-18
- 浏览6
JAMA
55-62页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



